---
granola_id: dc97432b-da4b-4fe1-811c-167d391fd607
title: "Catch-up Call with Virtue and Bessemer"
type: note
created: 2025-06-24T14:11:54.868Z
updated: 2025-07-10T23:18:00.295Z
attendees:
  - Morgan Cheatham
  - Sean Doolan
  - Sofia Guerra
  - Steve Kraus
---
### Portfolio Company Updates

- Made investment in Will Johnson’s company (breaking usual rules)
- Invested in Autonomy Health (NeuroFocus MSO)
	- $2.5M round with Natalie Kerns (TCV) and Rochelle Shaw
	- Focus on in-office infusions
	- One of few MSO pitches that resonated
	- Working with first couple practices and establishing GPO relationships

### Market Discussion - Neurology Space

- Discussing House Rx’s potential expansion into neurology
- Benefits of in-office infusions model:
	- Cost savings from hospital outpatient to in-office care
	- Revenue driver for providers
	- Potential partnerships with primary care organizations managing dementia/Alzheimer’s populations

### Investment Landscape

- Lightspeed won Will Johnson deal (competing with GC)
	- Lightspeed planning to invest $150-200M over next 5 years
	- Planning 2-3 similar investments per year
- Seed stage observations from Sofia:
	- Made investment in Cengage (home care space, AI scheduling)
	- Looking at earlier stage companies

### Payer Technology Discussion

- Sofia’s observations on payer technology:
	- Spent first half of year examining payer opportunities
	- Challenge: Payers reluctant to partner with startups
	- Reviewed Autonomize:
		- Has real customers and expanded presence
		- More traction than Anterior
		- Focused on utilization management and member engagement
		- Still very early stage
	- Noted challenge with payer pilots: $2M contracts often remain in testing phase

### Next Steps

- Sofia planning Austin visit (targeting October)
- Planning to organize breakfast meeting with local founders
- Sofia to reach out to Harry
- Emre available Tuesdays/Thursdays in New York

Chat with meeting transcript: https://notes.granola.ai/d/dc97432b-da4b-4fe1-811c-167d391fd607
